Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-18

FDA Approved: HALOPERIDOL — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves the original application for HALOPERIDOL, a generic product manufactured by Novadoz Pharmaceuticals LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HALOPERIDOL (HALOPERIDOL LACTATE)

Snippet

ORIG AP for HALOPERIDOL (HALOPERIDOL)